ScholarIQanswers from OpenAlex & ORCID
Mark J. DiNubile
ResearcherPublications, citations & collaboration network
Mark J. DiNubile is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark J. DiNubile have?
ScholarIQindexed works
Mark J. DiNubile has 219 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark J. DiNubile have?
ScholarIQcitation count
Mark J. DiNubile has 17,968 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark J. DiNubile?
ScholarIQh-index
Mark J. DiNubile has an h-index of 54 in OpenAlex.
What is the i10-index of Mark J. DiNubile?
ScholarIQi10-index
Mark J. DiNubile has an i10-index of 142 in OpenAlex.
What is the OpenAlex record for Mark J. DiNubile?
ScholarIQopenalex
The OpenAlex for Mark J. DiNubile is on the source record.
What are the most-cited papers on Mark J. DiNubile?
ScholarIQmost cited works
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M. Marty, Per Ljungman, Roy F. Chemaly, Johan Maertens, Sanjeet Dadwal, Rafael F. Duarte, Shariq Haider, Andrew J. Ullmann, Yuta Katayama, Janice Brown, Kathleen M. Mullane, Michael Boeckh, Emily A. Blumberg, Hermann Einsele, David R. Snydman, Yoshinobu Kanda, Mark J. DiNubile, Valerie Teal, Hong Wan, Yoshihiko Murata, Nicholas A. Kartsonis, Randi Y. Leavitt, Cyrus Badshah
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases
Thomas J. Walsh, John W. Hiemenz, Nita L. Seibel, John R. Perfect, Gary Horwith, Lily Lee, Jeffrey L. Silber, Mark J. DiNubile, Annette C. Reboli, Eric J. Bow, John Lister, Elias Anaissie
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults
Frances Priddy, Deborah D. Brown, James G. Kublin, Kathleen Monahan, David P. Wright, Jacob Lalezari, Steven Santiago, Michael Marmor, Michelle Lally, Richard M. Novak, Stephen J. Brown, P.P. Kulkarni, Sheri Dubey, Lisa Kierstead, Danilo R. Casimiro, Robin Mogg, Mark J. DiNubile, John W. Shiver, Randi Y. Leavitt, Michael Robertson, Devan V. Mehrotra, Erin Quirk, Merck V520‐016 Study Group
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women
Ole‐Erik Iversen, María J. Miranda, Àngels Ulied, Terje Soerdal, Erica Lazarus, Kulkanya Chokephaibulkit, Stan L. Block, A Skřivánek, Abdul Ghani Nur Azurah, Siew Moy Fong, Vladimír Dvořák, Kyung‐Hyo Kim, Ramón M. Cestero, Matitiahu Berkovitch, Mehmet Ceyhan, Misoo C. Ellison, Michael Ritter, Shuai Yuan, Mark J. DiNubile, Alfred J. Saah, Alain Luxembourg